Navigation Links
NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
Date:9/21/2007

bsequent 12-week study period.

Anthony A. DiTonno, President and CEO, commented, "I am very pleased with our ability to complete the enrollment of this study ahead of plan. When we completed our initial public offering earlier this year, we indicated that we would file a new drug application (NDA) with the Food and Drug Administration (FDA) in the second half of 2008. Completion of enrollment in this study, on top of our three already completed successful Phase 3 trials, increases our confidence that we can meet this goal."

NeurogesX has successfully completed two Phase 3 studies in postherpetic neuralgia (PHN) and one in HIV-DSP. NGX-4010 has been granted orphan status and has received fast track designation from the FDA for HIV-DSP. NeurogesX believes that it is on track to file for marketing approval in the European Union before the end of 2007 for a broad indication of peripheral neuropathic pain. The Company is currently evaluating various regulatory filing strategies in the United States in order to most efficiently seek FDA approval of both the PHN and HIV-DSP indications, and believes that it will be able to submit a new drug application with the FDA in 2008.

About PHN and HIV-DSP

PHN is a painful condition affecting sensory nerve fibers. It is a complication of shingles, a second outbreak of the varicella-zoster virus, which initially causes chickenpox. Following an initial infection, some of the virus can remain dormant in nerve cells. Years later, age, illness, stress, medications or other factors that are not well understood can lead to reactivation of the virus. The rash and blisters associated with shingles usually heal within six weeks, but some people continue to experience pain for years thereafter. This pain is known as postherpetic neuralgia. PHN may occur in almost any area, but is especially common on the torso.

HIV-DSP is caused primarily by three factors: direct activation of cells known as sensory neurons by the
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
2. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
3. Celsion Completes Enrollment in Phase I Liver Cancer Study
4. LANI completes Phase I in Japan and to commence Phase I in UK
5. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
8. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... SAN FRANCISCO, Calif. , Aug. 4, 2015 /PRNewswire/ ... results for the second quarter and six months ended ... studies with fostamatinib in ITP are progressing and we ... said Raul Rodriguez , president and chief executive ... advancement of our other clinical programs, including evaluating fostamatinib ...
(Date:8/4/2015)... 4, 2015  Dr. Keesha Ewers ... FDA approval of flibanserin, or what is being ... treatment of decreased female sexual desire back several ... causes and addressing libido as a singular symptom ... Photo - ...
(Date:8/4/2015)... 2015  MEI Pharma, Inc. (Nasdaq: MEIP ), an ... for cancer, announced today that Daniel P. Gold , ... 2015 Wedbush PacGrow Healthcare Conference on Tuesday, August 11, 2015 ... in New York . A live ... . A replay will be available approximately one hour after ...
Breaking Medicine Technology:Rigel Announces Second Quarter 2015 Financial Results 2Rigel Announces Second Quarter 2015 Financial Results 3Rigel Announces Second Quarter 2015 Financial Results 4Rigel Announces Second Quarter 2015 Financial Results 5Rigel Announces Second Quarter 2015 Financial Results 6Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5MEI Pharma to Present at Wedbush PacGrow Healthcare Conference 2
... the twelfth consecutive year, Rev. Nicholas Hood, III, Senior Minister, ... during New Year,s Eve celebrations. Rev. Hood, in partnership ... and the Wayne County Sheriff,s Office, is asking Detroiters and ... The hope is that there will be no injuries ...
... , NEW HAVEN, Conn., Dec. 30 VION ... today that the U.S. Food and Drug Administration ("FDA") had ... the Phase III randomized trial HOVON AML 92 sponsored by ... lead product Onrigin(TM). The FDA raised concerns with the HOVON ...
Cached Medicine Technology:Rev. Nick Hood, III Asks Southeast Michiganders Not to Use Guns During New Year's Eve Celebrations 2Vion Pharmaceuticals Announces FDA Conclusion 2Vion Pharmaceuticals Announces FDA Conclusion 3
(Date:8/4/2015)... ... August 04, 2015 , ... World ... Assisted Dumbbell Bench Rack, a fitness invention that eliminates the need to have ... Health and Fitness Clubs industry is worth $30 billion," says Scott Cooper, CEO ...
(Date:8/4/2015)... East Providence, RI (PRWEB) , ... August 04, 2015 , ... ... new satellite imaging center in the George Washington Medical Building on Wake Robin Road ... More importantly, the Wake Robin office will offer the most extensive out-patient x-ray hours ...
(Date:8/4/2015)... TX (PRWEB) , ... August 04, 2015 , ... Bayco ... factor small enough to fit, for example, on hard hats that have a flip-up ... Dual-Light Headlamp allows users to work without having to remove their headlamp when ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... School is ... summer in the sun and preparing for the back-to-school scramble. Dublin, OH family ... is the best time for the annual dental checkup. In fact, the dentist recently ...
(Date:8/4/2015)... , ... August 04, 2015 , ... Members receiving care ... care metrics – at a cost that is nine percent lower -- than those ... Blue Shield of New Jersey’s patient-centered programs. , “The promise of patient-centered, or ...
Breaking Medicine News(10 mins):Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 2Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 4Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3
... is a fungal infection affecting mostly children in North America. ... affected by ringworm infections. //It is a highly contagious skin ... symptoms such as scaly scalp and hair loss which can ... household pets but in rare occasions it is passed easily ...
... a new vitamin-A drug, which may be helpful in ... but also added that more research is needed before ... charity committed to fighting breast cancer through research and ... women between 12 and 16 years, reported the online ...
... that grow without the primary protein linked to soy ... scientists//. ,The two lines already are adapted to ... seeking to produce new varieties of allergy-free soybeans without ... of Illinois at Urbana-Champaign and the USDA-Agricultural Research Service's ...
... treatment to create a "saviour sibling" for their seriously-ill 20-month-old ... licence to a clinic allowing it to use controversial testing ... donor for a very ill baby. ,Charlotte Mariethoz, ... anaemia and her only hope of survival is by a ...
... and Aberdeen University in Scotland found that women with ... have twins// following in vitro fertilization. They found that ... multiple births after fertility treatment. ,However, the ... protects against birth defects such as spina bifida, does ...
... Zoloft (sertraline) may avoid in preventing recurring of depression ... between the depressive episodes. ,One in every four ... study, reports foodconsumer.org. ,Researchers studied 152 diabetics, ... from depression during treatment with Zoloft -- 79 of ...
Cached Medicine News:Health News:Promise for Soya Allergy Sufferers 2Health News:High Levels Of Folic Acid May Increase The Chances Of Twins After IVF 2
... and is variably N-glycosylated. The variation accounts for ... and 56 kDa. Insulin-like growth factor binding proteins ... do not bind insulin. Of the six distinct ... IGFBP-3 has been shown to be the major ...
... Antibodies (ANAs) has long been an important ... diseases. The antigens used in their detection ... human or animal nuclei, this has led ... (ENAs). The most commonly measured ENA specifications ...
... detection of Anti-Nuclear Antibodies (ANAs) has long ... of systemic rheumatic diseases. The antigens used ... saline extraction of human or animal nuclei, ... Extractable Nuclear Antigens (ENAs). The most commonly ...
Combined Screen (RNP, Sm, Jo-1, Scl-70, SS-A, SS-B) ELISA kit....
Medicine Products: